<SEC-DOCUMENT>0001213900-23-014561.txt : 20230227
<SEC-HEADER>0001213900-23-014561.hdr.sgml : 20230227
<ACCEPTANCE-DATETIME>20230227074611
ACCESSION NUMBER:		0001213900-23-014561
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20230227
FILED AS OF DATE:		20230227
DATE AS OF CHANGE:		20230227

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SciSparc Ltd.
		CENTRAL INDEX KEY:			0001611746
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38041
		FILM NUMBER:		23670070

	BUSINESS ADDRESS:	
		STREET 1:		20 RAUL WALLENBERG STREET, TOWER A
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6971916
		BUSINESS PHONE:		972-3-6103100

	MAIL ADDRESS:	
		STREET 1:		20 RAUL WALLENBERG STREET, TOWER A
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6971916

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SciSparc Ltd./ADR
		DATE OF NAME CHANGE:	20210129

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Therapix Biosciences Ltd.
		DATE OF NAME CHANGE:	20140624
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea174175-6k_scisparc.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form 6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Report of Foreign Private Issuer<BR>
Pursuant to Rule 13a-16 or 15d-16</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">under the Securities Exchange Act of 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the month of February 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Report No. 4)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Commission file number: 001-38041</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SCISPARC LTD.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Translation of registrant&rsquo;s name into English)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>20 Raul Wallenberg Street, Tower A,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Tel Aviv 6971916 Israel</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form 20-F <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT>
Form 40-F <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>CONTENTS</U></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
February 23, 2023 (the &ldquo;Effective Date&rdquo;), SciSparc Ltd. (the &ldquo;Company&rdquo; or &ldquo;SciSparc&rdquo;) entered into
a stock purchase agreement (the &ldquo;Agreement&rdquo;) with Jeffs&rsquo; Brands Holdings Inc., a recently newly-formed wholly owned
subsidiary (&ldquo;NewCo Inc.&rdquo;) of Jeffs&rsquo; Brands Ltd. (&ldquo;Jeffs&rsquo; Brands&rdquo;) (Nasdaq: JFBR, JFBRW), and Jeffs&rsquo;
Brands, pursuant to which, at the closing and upon the terms and conditions set forth in the Agreement, NewCo Inc. will acquire from SciSparc
a number of shares of stock equal to approximately a 49% interest in SciSparc&rsquo;s wholly owned subsidiary, SciSparc Nutraceuticals
Inc. (the &ldquo;Subsidiary&rdquo;), which owns WellutionTM&nbsp;, a top-selling Amazon.com Marketplace brand, for $2.5 million in cash,
subject to certain purchase price adjustments related to inventory and working capital, which adjustments are expected to increase the
purchase price by approximately $300,000.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
closing of the transactions is subject to certain customary conditions and is expected to be completed within seven business days from
the Effective Date (the &ldquo;Closing&rdquo;). Following the Closing, which includes an equity conversion of financing amounts previously
provided to the Subsidiary by SciSparc for working capital, SciSparc will hold approximately 51% of the Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Agreement also provides that at the Closing Jeffs Brands and the Subsidiary will enter into a consulting agreement, pursuant to which
Jeffs&rsquo; Brands will provide management services to the Subsidiary for the WellutionTM brand for a monthly fee of $20,000 and Jeffs&rsquo;
Brands will receive a one-time signing bonus in the amount of $51,000. The consulting agreement will be for an undefined period of time
and may be terminated by either party with 30 days advance notice.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
addition, pursuant to the Agreement, at the Closing, Jeffs&rsquo; Brands and SciSparc will undertake a share exchange in which the Company
will acquire a number of ordinary shares of Jeffs&rsquo; Brands and Jeffs&rsquo; Brands will acquire a number of ordinary shares of the
Company (collectively, the &ldquo;Exchange Shares&rdquo;), in each case having an aggregate value of $300,000, from each of SciSparc and
Jeffs&rsquo; Brands, respectively. The issuance of the Exchange Shares includes a limit on either party beneficially owning an amount
in excess of 4.99% of the issued and outstanding share capital of one another immediately following the share exchange. The number of
Exchange Shares to be acquired by each company will be calculated based on the average closing price of the relevant company&rsquo;s shares
on the Nasdaq Capital Market for the 30 consecutive trading days ending on the third trading day immediately prior to the Closing.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Neither the Subsidiary stock
to be received by Jeffs&rsquo; Brands nor the Exchange Shares will be registered under the Securities Act of 1933, as amended (the &ldquo;Securities
Act&rdquo;), or any state&rsquo;s securities laws and such stock and Exchange Shares will be issued pursuant to an exemption from registration
under the Securities Act. Neither the Subsidiary stock nor the Exchange Shares may not be offered or sold in the United States by the
receiving party, except pursuant to an effective registration statement or an applicable exemption from the registration requirements
of the Securities Act.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">The representations, warranties and covenants of
SciSparc, NewCo Inc. and Jeffs&rsquo; Brands contained in the Agreement have been made solely for the benefit of the parties thereto and not any other
person. Accordingly, the Agreement is included with this filing only to provide investors with information regarding the terms of the
Agreement, and not to provide investors with any factual or other information regarding SciSparc, Jeffs&rsquo; Brands, NewCo Inc. or their respective
subsidiaries or affiliates.&nbsp;Investors&nbsp;should&nbsp;not rely on the representations, warranties and covenants or any descriptions
thereof as characterizations of the actual state of facts or condition of SciSparc, Jeffs&rsquo; Brands, NewCo Inc. or any of their respective subsidiaries
or affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">To
announce the transaction, the Company issued a press release on February 23, 2023, titled &ldquo;SciSparc Signs a Definitive Agreement
to Sell 49% interest in its Subsidiary that Owns Wellution for $2.5 million,&rdquo; a copy of which is furnished as Exhibit 99.1 with
this Report of Foreign Private Issuer on Form 6-K (the &ldquo;Form 6-K&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A copy of the Agreement is
filed as Exhibit 99.2 to this Form 6-K and is incorporated by reference herein. The foregoing summary of the Agreement is subject to and
qualified in its entirety by reference to Exhibit 99.2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, on February 22,
2023, the Company issued a press release titled &ldquo;SciSparc and Clearmind Reveal Three Unique Combinations of Future Psychedelic-Based
Compounds.&rdquo; A copy of this press release is furnished herewith as Exhibit 99.3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Report on Form 6-K, including
its exhibits (with respect to: (i) Exhibit 99.1 hereto, the first two and sixth paragraphs and the section entitled &ldquo;Forward-Looking
Statements&rdquo; only; (ii) Exhibit 99.2 hereto; and (iii) Exhibit 99.3 hereto only), is incorporated by reference into the registration
statements on Form F-3 (File No. <A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390023012516/ea172999-f3_scisparc.htm">333-269839</A>, File No. <A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390022037966/ea162219-f3_scisparcltd.htm">333-266047</A>, File No. <A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390019016523/ff32019_therapixbio.htm">333-233417</A> and File No. <A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390022022376/ea158932-posam_scisparcltd.htm">333-248670</A>) and on Form S-8 (File No.
<A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390018008005/fs82018_therapixbiosciences.htm">333-225773</A>) filed with the Securities and Exchange Commission to be a part thereof from the date on which this report is submitted, to
the extent not superseded by documents or reports subsequently filed or furnished.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT INDEX</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
<TD STYLE="border-bottom: black 1.5pt solid"><B>Exhibit No.</B></TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
<TD STYLE="text-align: justify">99.1</TD>
<TD STYLE="text-align: justify">&nbsp;</TD>
<TD STYLE="text-align: justify"><A HREF="ea174175ex99-1_scisparc.htm">Press Release issued by SciSparc Ltd. on February 23, 2023 titled &ldquo;SciSparc Signs a Definitive Agreement to Sell 49% interest in its Subsidiary that Owns Wellution for $2.5 million.&rdquo;</A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
<TD STYLE="text-align: justify">99.2</TD>
<TD STYLE="text-align: justify">&nbsp;</TD>
<TD STYLE="text-align: justify"><A HREF="ea174175ex99-2_scisparc.htm">Stock Purchase Agreement, dated February 23, 2023, by and between SciSparc Ltd., NewCo Inc. and Jeffs&rsquo; Brands Ltd.</A></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
<TD STYLE="text-align: justify">99.3</TD>
<TD STYLE="text-align: justify">&nbsp;</TD>
<TD STYLE="text-align: justify"><A HREF="ea174175ex99-3_scisparc.htm">Press Release issued by SciSparc Ltd. on February 22, 2023 titled &ldquo;SciSparc and Clearmind Reveal Three Unique Combinations of Future Psychedelic-Based Compounds.&rdquo;</A></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SIGNATURES</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>SciSparc Ltd.</B> <TR STYLE="vertical-align: top"><TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">Date: February 27, 2023</TD>
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 35%">/s/ Oz Adler</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:&nbsp;</TD>
    <TD>Oz Adler</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD STYLE="text-align: justify">Chief Executive Officer and<BR>
Chief Financial Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea174175ex99-1_scisparc.htm
<DESCRIPTION>PRESS RELEASE ISSUED BY SCISPARC LTD. ON FEBRUARY 23, 2023 TITLED "SCISPARC SIGNS A DEFINITIVE AGREEMENT TO SELL 49% INTEREST IN ITS SUBSIDIARY THAT OWNS WELLUTION FOR $2.5 MILLION."
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 18pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Exhibit 99.1</B></FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 12pt"><B>SciSparc Signs a Definitive Agreement
to Sell 49% interest in its Subsidiary that Owns Wellution for $2.5 million</B></FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">TEL AVIV, Israel, Feb. 23, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq:
SPRC) (&ldquo;Company&rdquo; or &ldquo;SciSparc&rdquo;), a specialty clinical-stage pharmaceutical company focusing on the development
of therapies to treat disorders of the central nervous system, today announced it has signed a definitive agreement to sell a 49% interest
in its wholly owned subsidiary, SciSparc Nutraceuticals Inc. (the &ldquo;Subsidiary&rdquo;), which owns Wellution<SUP>TM</SUP>&nbsp;,
a top-selling Amazon.com Marketplace brand (&ldquo;Wellution&rdquo;), to a wholly-owned subsidiary of Jeffs&rsquo; Brands Ltd. (&ldquo;Jeffs&rsquo; Brands&rdquo;)(Nasdaq:
JFBR), a data-driven e-commerce company operating on Amazon, for $2.5 million in cash, subject to certain purchase price adjustments related
to inventory and working capital expected to increase the purchase price by approximately $300,000, plus a mutual share exchange in the
amount of $300,000 of ordinary shares from each of SciSparc and Jeffs&rsquo; Brands. The number of shares in the share exchange will be
calculated based on the average closing price of the relevant company&rsquo;s shares for 30 consecutive trading days ending on the third
trading day immediately prior to closing the transaction. Following the closing of the transaction, which includes an equity conversion
of financing amounts previously provided to the Subsidiary by SciSparc, SciSparc will hold approximately 51% of the Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Closing of the transaction is subject to certain customary conditions
and is expected to be completed within seven business days. At closing, Jeffs&rsquo; Brands and the Subsidiary will enter into a consulting
agreement by which Jeffs&rsquo; Brands will provide management services for Wellution for a monthly fee of $20,000. The agreement is for
an undefined period of time and may be terminated by either party with 30-days&rsquo; advance notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;The agreement expands our collaboration with Jeffs&rsquo; Brands
for the online marketing and sale on Amazon of food supplement products following our recent letter of intent signed with Jeffs&rsquo;
Brands for the development of a new food supplements product line and the online marketing of such supplements. We are pleased to have
Jeffs&rsquo; Brands as our partner which we believe will strengthen the Wellution brand,&rdquo; said Oz Adler, Chief Executive Officer of SciSparc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Wellution&trade; sells dozens of hemp-based, top-ranked products, including
hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other
beauty and hair treatment products that are all manufactured in the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Wellution&trade; offers eight variations of natural hemp candy supplements
under two parent Amazon Standard Identification Numbers (&ldquo;ASIN&rdquo;) on Amazon that are differentiated by their hemp oil potency.
The leading parent ASIN, that was launched in 2019, has received over 26,500 reviews and is consistently ranked as the #1 best seller
in the category. In total, the brand has approximately 40,000 product reviews, most of which are 4 and 5-star reviews.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr. Oz Adler, the Chief Executive Officer and the Chief Financial Officer
of the Company, is the Chairman of the board of directors of Jeffs&rsquo; Brands. The Chairman of the Company, Mr. Amitay Weiss, and Mr.
Moshe Revach are members of the board of directors of both SciSparc and Jeffs&rsquo; Brands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About SciSparc Ltd. (Nasdaq: SPRC):</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">SciSparc Ltd. is a specialty clinical-stage pharmaceutical company
led by an experienced team of senior executives and scientists. SciSparc&rsquo;s focus is on creating and enhancing a portfolio of technologies
and assets based on cannabinoid pharmaceuticals. With this focus, the Company is currently engaged in the following drug development programs
based on THC and/or non-psychoactive cannabidiol (CBD): SCI-110 for the treatment of Tourette Syndrome, for the treatment of Alzheimer&rsquo;s
disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of autism spectrum disorder and status epilepticus.
The Company also owns the Subsidiary, whose business focusses on the sale of hemp-based products on the Amazon.com marketplace.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This press release contains forward-looking statements within the meaning
of the &ldquo;safe harbor&rdquo; provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws.
For example, SciSparc is using forward-looking statements when it discusses the expected closing of the transaction contemplated by the
definitive agreement described above, including potential future cash payments, the sale and consulting arrangement and an exchange of
shares between the Company and Jeffs&rsquo; Brands, and collaboration with Jeffs&rsquo; Brands to strengthen the Wellution brand. Because
such statements deal with future events and are based on SciSparc&rsquo;s current expectations, they are subject to various risks and uncertainties
and actual results, performance or achievements of SciSparc could differ materially from those described in or implied by the statements
in this press release. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties,
including those discussed under the heading &ldquo;Risk Factors&rdquo; in SciSparc&rsquo;s Annual Report on Form 20-F filed with the U.S. Securities
and Exchange Commission (the &ldquo;SEC&rdquo;) on April 28, 2022, and in subsequent filings with the SEC. Except as otherwise required
by law, SciSparc disclaims any intention or obligation to update or revise any forward-looking statements, which speak only as of the
date they were made, whether as a result of new information, future events or circumstances or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">IR@scisparc.com<BR>
Tel: +972-3-6167055</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>ea174175ex99-2_scisparc.htm
<DESCRIPTION>STOCK PURCHASE AGREEMENT, DATED FEBRUARY 23, 2023, BY AND BETWEEN SCISPARC LTD., NEWCO INC. AND JEFFS' BRANDS LTD
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.2</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-decoration: none">STOCK
PURCHASE AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This <B>STOCK PURCHASE AGREEMENT</B>
(this &ldquo;<B>Agreement</B>&rdquo;) is made and entered into as of February 23, 2023 (the &ldquo;<B>Effective Date</B>&rdquo;) by and
between SciSparc Ltd., a company organized under the laws of the State of Israel (the &ldquo;<B>Seller</B>&rdquo;) and NewCo Inc., a company
to be incorporated under the laws of the State of Delaware, as a wholly-owned subsidiary of Jeffs&rsquo; Brands Ltd, a company organized
under the laws of the State of Israel (the &ldquo;<B>Purchaser</B>&rdquo; and the &ldquo;<B>Parent</B>&rdquo;, respectively, and collectively,
the &ldquo;<B>Purchasers</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, subject to
the terms and conditions set forth in this Agreement, Seller wishes to sell and transfer to Purchaser, and Purchaser wishes to acquire
from Seller 56 shares of common stock, par value $0.01 per share (&ldquo;<B>Common Stock</B>&rdquo;) of SciSparc Nutraceuticals Inc.,
a company incorporated under the laws of the State of Delaware and a wholly-owned subsidiary of Seller (the &ldquo;<B>Seller Subsidiary</B>&rdquo;)
for an aggregate purchase price of $2,500,000, subject to adjustments (the &ldquo;<B>Seller Shares</B>&rdquo;); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Seller
Subsidiary owns the Wellution brand, which is engaged in the business of designing, producing and selling hemp based food supplements
and health and cosmetic products, conducted on various online sales channels, including, Amazon.com (the &ldquo;<B>Business</B>&rdquo;
and the &ldquo;<B>Business Inventory</B>&rdquo;, respectively).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>, the
parties hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">1. </FONT><U>TRANSACTIONS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">1.1 <U>Sale
and Purchase of Seller Shares</U>. At the Closing (as defined below) and subject to the terms and conditions of this Agreement, the Seller
agrees to sell and transfer to the Purchaser, and Purchaser agrees to purchase from Seller, the Seller Shares representing approximately
49% of shares of the Seller Subsidiary&rsquo;s issued and outstanding Common Stock (rounded to the nearest whole number), at a price per
share of $44,302.68 (the &ldquo;<B>PPS</B>&rdquo;), for an aggregate purchase amount of $2,500,000, subject to adjustments (the &ldquo;<B>Purchase
Price</B>&rdquo;) following which the Purchaser shall hold approximately 49% of the capital stock of the Seller Subsidiary on a fully
diluted basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">1.2 <U>Purchase
Price</U>. The Purchase Price shall be delivered by the Purchaser to the Seller in cash <I>plus</I> the Price Adjustment (as defined below),
which shall be due upon the Closing (such amount following such adjustments, the &ldquo;<B>Base Payment</B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">1.3 <U>Share
Exchange.</U> At the Closing and subject to the terms and conditions of this Agreement: (i) the Seller agrees to sell and transfer to
the Parent, and the Parent agrees to purchase and accept from the Seller, such number of Ordinary Shares, no par value of the Seller (the
&ldquo;<B>Seller Exchange Shares</B>&rdquo;), as set forth in <B><U>Schedule I</U></B> hereto and (ii)&nbsp;in exchange for the transfer
of the Seller Exchange Shares, the Parent agrees to sell and transfer to the Seller and the Seller agrees to purchase and accept from
the Parent, such number of Ordinary Shares, no par value of the Parent (the &ldquo;<B>Parent Exchange Shares</B>&rdquo;), as set forth
in <B><U>Schedule I</U></B> hereto, each at an aggregate value of $300,000 (the &ldquo;<B>Exchange</B>&rdquo;, and the Seller Exchange
Shares and the Parent Exchange Shares collectively, the &ldquo;<B>Exchange Shares</B>&rdquo;). Neither the Seller nor the Parent shall
issue any amount of Exchange Shares, to the extent that after giving effect to such issuance, the respective holder hereunder would beneficially
own an amount in excess of 4.99% of the number of Ordinary Shares of the respective company, as issued and outstanding immediately following
the Closing. Accordingly, the value of the Exchange Shares shall be mutually adjusted to reflect an equal value of Exchange Shares to
be exchanged between the Seller and the Parent. The Seller Shares and the Exchange Shares shall be hereinafter referred to collectively
as the &ldquo;<B>Shares</B>&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">1.4 <U>Price
Adjustments.</U> At the Closing and subject to the terms and conditions of this Agreement, the Purchase Price shall be increased by the
dollar value equal to 49% of the following: (i) the Business Inventory, including any Business Inventory located in Seller Subsidiary&rsquo;s
warehouses, in the Amazon.com warehouses, and any Business Inventory ordered and paid for by the Seller Subsidiary and is pending receipt;
(ii) any outstanding funds due from Amazon.com for sales from the Seller Subsidiary&rsquo;s Business and (iii) the cash balance amount
of the Seller Subsidiary as of the Closing (the &ldquo;<B>Business Assets</B>&rdquo;), in such amount as set forth in <B><U>Schedule II
hereto</U></B> (the &ldquo;<B>Price Adjustment</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">1.5 <U>Conversion
of Financing Amount</U>. The Purchaser hereby acknowledges that as of the date hereof, the Seller has made available to the Seller Subsidiary
financing amounts in the total amount of approximately US$ 600,000 (the &ldquo;<B>Financing Amount</B>&rdquo;), all of which is currently
outstanding and bears interest at a rate equivalent to the minimal interest rate applied by the Israel Tax Authority, as such may be adjusted
from time (together with any interest accrued thereon, the &ldquo;<B>Debt Amount</B>&rdquo;). Subject to the terms and conditions of this
Agreement, immediately prior to and subject to the Closing, the Seller Subsidiary shall issue to the Seller, 14 shares of Common Stock,
allocated, at the PPS per each share of Common Stock, as conversion of the Debt Amount (the &ldquo;<B>Conversion Shares</B>&rdquo;). Upon
the conversion of the Debt Amount and the issuance of the Conversion Shares, the Seller Subsidiary will have no further obligations with
respect thereto or pursuant to the Financing Amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">1.6 <U>Consulting
Agreement</U>. At the Closing, the Seller Subsidiary and the Purchaser shall enter into a consulting agreement for the provision of management
services relating to the Business, substantially in the form attached hereto as <B><U>Exhibit A</U></B> (the &ldquo;<B>Consulting Agreement</B>&rdquo;).
In accordance with the terms of the Consulting Agreement, at the Closing, the Seller shall cause the Seller Subsidiary to grant to the
Purchaser a one-time signing bonus equal (the &ldquo;<B>Signing Bonus</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in"><B>1.7 </B><U>Restated
Bylaws</U>. On or immediately prior to the Closing, the Seller shall cause the Seller Subsidiary to adopt the Amended and Restated Bylaws
of the Seller Subsidiary in the form attached hereto as <B><U>Exhibit B</U></B> (the &ldquo;<B>Restated Bylaws</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">1.8 <U>Signatory
Rights</U>. On or immediately prior to the Closing, the Seller shall cause the Seller Subsidiary to adopt the signatory rights of the
Seller Subsidiary, as set form in the form attached hereto as <B><U>Exhibit C</U></B> (the &ldquo;<B>Signatory Rights</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">1.9 <U>Closing</U>.
The closing of the transactions contemplated by this Agreement (the &ldquo;<B>Closing</B>&rdquo; and the &ldquo;<B>Transactions</B>&rdquo;,
respectively) shall take place remotely via exchange of signature pages, subject to the satisfaction (or waiver by the applicable party)
of the Closing conditions in Section 3 below, within seven business days following the Effective Date (the &ldquo;<B>Closing Date</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">2. </FONT><U>DELIVERIES</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">2.1 <U>Delivery
by Seller</U>. On or prior to the Closing, the Seller shall deliver or caused to be delivered to the Purchaser, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(a) this
Agreement duly executed by the Seller;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(b) true
and correct copies of written resolutions, or minutes of a meeting, of the board of directors of the Seller Subsidiary, approving and
adopting in all respects the execution, delivery and performance of this Agreement and the Transactions contemplated hereby;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(c) true
and correct copies of written resolutions, or minutes of meeting, of the audit committee and board of the directors of the Seller, approving
and adopting in all respects the execution, delivery and performance of this Agreement and the Transactions contemplated hereby;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(d) a
Stock Power duly executed by the Seller and indicating the number of Seller Shares sold by it, in the form attached hereto as <B><U>Exhibit&nbsp;D</U></B>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(e) duly
executed stock certificates evidencing the Seller Shares in the Purchaser&rsquo;s name, if so requested by the Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(f) the
Seller Exchange Shares;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(g) the
Signing Bonus;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(h) a
copy of the stockholders&rsquo; ledger of the Seller Subsidiary, certified by an executive officer of the Seller Subsidiary, in which
the Seller Shares issued at the Closing are registered in the name of Purchaser, in the form attached hereto as <B><U>Schedule 2.1(h)</U></B>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(i) a
copy of the Restated Bylaws as approved by the sole stockholder of the Seller Subsidiary;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(j) the
Signatory Rights as approved by the Board of Directors of the Seller Subsidiary; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(k) wire
instructions, on its letterhead and executed by the Seller Subsidiary&rsquo;s President (the &ldquo;<B>Wire Instructions</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">2.2 <U>Delivery
by Purchasers</U>. On or prior to the Closing, the Purchasers shall deliver or cause to be delivered to the Seller, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(a)
this Agreement duly executed by the Purchasers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(b) true
and correct copies of written resolutions, or minutes of a meeting, of the board of directors of the Purchaser, approving and adopting
in all respects the execution, delivery and performance of this Agreement and the Transactions contemplated hereby;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(c) true
and correct copies of written resolutions, or minutes of meeting, of the audit committee and board of the directors of the Parent, approving
and adopting in all respects the execution, delivery and performance of this Agreement and the Transactions contemplated hereby;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(d) evidence
of a wire transfer of immediately available funds of the Base Payment to the account designated by Seller in the Wire Instructions; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(e) the
Parent Exchange Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">3. </FONT><U>CLOSING
CONDITIONS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">3.1 The
obligations of each of the Seller and the Purchasers hereunder in connection with the Closing are subject to the following conditions
being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(a) the
accuracy in all material respects when made and at the Closing, of the representations and warranties of each of the Seller and Purchasers,
as applicable, contained herein</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(b) all
obligations, covenants and agreements of each of the Seller and Purchasers, as applicable, required to be performed at or prior to the
Closing shall have been performed; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(c) the
delivery by the Seller and the Purchasers of the items set forth in <U>Sections 2.1 and 2.2</U>, as applicable, of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">4. </FONT><U>REPRESENTATIONS
AND WARRANTIES OF THE SELLER</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in">The Seller hereby represents
and warrants to the Purchasers that the following representations and warranties are true and correct in all respects as of the Closing
Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">4.1 <U>Authorization;
Validity.</U> The Seller is duly incorporated and validly existing under the laws of the State of Israel. The Seller has the requisite
corporate power and authority to execute and deliver this Agreement and to perform its obligations hereunder. All corporate action required
to be taken by the Sellers&rsquo;s board of directors in order to authorize the Seller to enter into this Agreement and all exhibits,
schedules and ancillary documents thereto (collectively, the &ldquo;<B>Transaction Agreements</B>&rdquo;), and to transfer the Seller
Shares and to issue the Seller Exchange Shares at the Closing. All action on the part of the officers of the Seller necessary for the
execution and delivery of the Transaction Agreements, the performance of all obligations of the Seller under the Transaction Agreements
to be performed as of the Closing, and the issuance and delivery of the Seller Shares and Seller Exchange Shares has been taken. This
Agreement has been duly executed and delivered and, assuming due execution and delivery by the other party, constitutes the valid and
binding obligation of the parties, enforceable in accordance with its terms and conditions except as may be limited by applicable bankruptcy,
insolvency, reorganization, moratorium laws, and other laws of general application affecting the enforcement of creditors&rsquo; rights
and remedies generally.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">4.2 <U>Consents.</U>
The Seller has obtained each consent, approval, permit, declaration, registration, and authorization of, and made each filing with, any
person, including any applicable court, governmental or regulatory authority, commission, administrative agency, and non-governmental
third party, if any, necessary to consummate the Transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">4.3 <U>Non
Contravention</U>. Neither the execution, delivery or performance by the Seller of this Agreement or any of the Transaction Agreements
to which it is a party, nor the consummation of the Transactions contemplated hereunder and thereunder, will (with or without notice or
lapse of time): (a) contravene, conflict with or result in a violation of (i) any provision of the organizational documents of the parties;
(ii) any applicable law; or (iii) any provision of any contract or agreement to which the Seller is a party; or (b) otherwise give any
person the right to (x) declare a default or exercise any remedy under any such contract or agreement, (y) accelerate the maturity or
performance of any such contract or agreement, or (z) cancel, terminate or modify any such contract or agreement, in each case, except
as would not have and would not reasonably be expected to have or result in an adverse effect on the ability of the Seller to consummate
the Transactions contemplated hereunder pursuant to the terms hereof or under the Transaction Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">4.4 <U>Title
to Seller Shares</U>. The Seller represents and warrants that other than with respect to applicable securities laws and the Seller Subsidiary&rsquo;s
bylaws (as in effect from time to time), Seller has good, marketable and valid title to and unrestricted power to vote and sell the Seller
Shares, free and clear of any lien, pledge, hypothecation, charge, mortgage, security interest, encumbrance, claim, infringement, interference,
option, right of first refusal, co-sale, tag along or drag along right, preemptive right, community property interest or restriction of
any nature (including any restriction on the voting of any security, any restriction on the transfer of any security or other asset, any
restriction on the receipt of any income derived from any asset, any restriction on the use of any asset and any restriction on the possession,
exercise or transfer of any other attribute of ownership of any asset) (collectively, &ldquo;<B>Encumbrances</B>&rdquo;) and, upon purchase
and payment therefor and delivery to the Purchaser in accordance with the terms of this Agreement, Purchaser will obtain good, marketable
and valid title to the Seller Shares and unrestricted power to vote and sell free and clear of any Encumbrances except for those contained
under applicable securities laws and the Seller Subsidiary&rsquo;s bylaws (as in effect from time to time). The Seller Shares have been
duly authorized and validly issued to Seller and are fully paid and non-assessable. The transfer of the Seller Shares by Seller to Purchaser
is not subject to any right of first refusal, preemptive, co-sale, tag-along or drag-along right or other comparable obligations or restrictions
that have not been validly waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">4.5 <U>Seller
Exchange Shares</U>. The Seller represents and warrants that the Seller Exchange Shares to be issued will be, when issued, in accordance
with the terms thereof, duly authorized, validly issued, fully paid and non-assessable and free of Encumbrances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(a) <U>Purchase
Entirely for Own Account.</U> The Parent Exchange Shares proposed to be acquired by the Seller hereunder will be acquired for investment
for the Seller&rsquo;s own account and not as a nominee or agent, and not with a view to the resale or distribution of any part thereof,
and the Seller has no present intention of selling, granting any participation in or otherwise distributing the Parent Exchange Shares,
except in compliance with applicable securities laws. The Seller further represents that it does not have any contract, undertaking, agreement
or arrangement with any Person to sell, transfer or grant participation to such Person with respect to the Parent Exchange Shares. For
purposes of this Agreement, &ldquo;<B>Person</B>&rdquo; means any individual, partnership, corporation, association, joint stock company,
trust, joint venture, unincorporated organization or governmental entity (or any department, agency or political subdivision thereof)
or other entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(b) The
Seller (i) can bear the economic risk of its investment and (ii) possesses such knowledge and experience in financial and business matters
that it is capable of evaluating the merits and risks of its investment in the other party and its securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(c) The
Seller understands that the sale of the Parent Exchange Shares is not registered under the Securities Act of 1933 (the &ldquo;<B>Securities
Act</B>&rdquo;) and that the issuance hereof is intended to be exempt from registration under the Securities Act pursuant to Regulation
D promulgated thereunder (&ldquo;<B>Regulation D</B>&rdquo;). The Seller is an &ldquo;accredited investor,&rdquo; as such term is defined
in Rule 501 of Regulation D or, if not an accredited investor, otherwise meets the suitability requirements of Regulation D and Section
4(a)(2) of the Securities Act. The certificates representing the Parent Exchange Shares issued shall be endorsed with the following legends,
in addition to any other legend required to be placed thereon by applicable securities laws:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0cm">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0cm">&ldquo;THIS SECURITY
HAS BEEN ACQUIRED FOR INVESTMENT AND HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT&nbsp;OF 1933, AS AMENDED (&ldquo;SECURITIES ACT&rdquo;),
OR APPLICABLE STATE SECURITIES OR &ldquo;BLUE SKY&rdquo; LAWS.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0cm">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0cm">&ldquo;TRANSFER OF THESE
SECURITIES IS PROHIBITED UNLESS A REGISTRATION STATEMENT UNDER THE SECURITIES ACT WITH RESPECT TO SUCH SECURITY SHALL THEN BE IN EFFECT
AND SUCH TRANSFER HAS BEEN QUALIFIED UNDER ALL APPLICABLE STATE SECURITIES OR &ldquo;BLUE SKY&rdquo; LAWS, OR AN EXEMPTION THEREFROM SHALL
BE AVAILABLE UNDER THE ACT AND SUCH LAWS.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(d) The
Seller acknowledges that neither the U.S. Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;), nor the securities regulatory
body of any state or other jurisdiction, has received, considered or passed upon the accuracy or adequacy of the information and representations
made in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(e) The
Seller acknowledges that it has carefully reviewed such information as it has deemed necessary to evaluate an investment in the other
party and its securities. To the full satisfaction of the Seller, it has been furnished all materials that it has requested relating to
the Parent Exchange Shares and the issuance of the Shares hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(f) The
Seller understands that the Parent Exchange Shares may not be sold, transferred, or otherwise disposed of without registration under the
Securities Act or an exemption therefrom, and that in the absence of an effective registration statement covering the Shares or any available
exemption from registration under the Securities Act, the Parent Exchange Shares may have to be held indefinitely and the Seller further
acknowledges that the Shares may not be sold pursuant to Rule 144 promulgated under the Securities Act unless all of the conditions of
Rule 144 are satisfied, including, without limitation, the Seller&rsquo;s compliance with the reporting requirements under the Securities
Exchange Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(g) <U>Additional
Legend; Consent</U>. Additionally, the Parent Exchange Shares will bear any legend required by the &ldquo;blue sky&rdquo; laws of any
state to the extent such laws are applicable to the securities represented by the certificate so legended and each party consents to the
other party making a notation on its records or giving instructions to any transfer agent of the Parent Exchange Shares in order to implement
the restrictions on transfer of the Parent Exchange Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">4.6 <U>Compliance</U>.
The Seller has not been advised, nor does it have reason to believe, that it is not conducting its business in compliance with all applicable
laws, rules and regulations of the jurisdictions in which it is conducting its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">4.7 <U>Conformity
of Descriptions</U>. The Seller Exchange Shares when issued, will conform in all material respects to the descriptions of the Shares contained
in the Seller&rsquo;s filings with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">4.8 <U>Disclosure
Controls</U>. The Seller has disclosure controls and procedures (as defined in Rule 13a-15 under the Exchange Act) that are designed to
ensure that material information relating to it is made known to its principal executive officer and principal financial officer or persons
performing similar functions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">4.9 <U>Disclosure</U>.
All disclosures provided to the Purchasers regarding the Seller, the Seller Subsidiary, its business and the Transactions contemplated
hereby, including the exhibits to this Agreement, furnished by the Seller with respect to the representations and warranties made herein
are true and correct with respect to such representations and warranties and do not contain any untrue statement of a material fact or
omit to state any material fact necessary in order to make the statements made therein, in light of the circumstances under which they
were made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">4.10 <U>No
Brokers</U>. No broker or finder has acted directly or indirectly for the Seller in connection with this Agreement or the Transactions,
and no broker or finder is entitled to any brokerage or finder&rsquo;s fee or other commission in respect thereof based in any way on
agreements, arrangements or understandings made by or on behalf of the Seller.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">4.11 <U>Exclusive
Representation</U>. The representations and warranties set forth in this Section 4 above are the only representations and warranties made
by the Seller with respect to the matters contained herein and other than as set forth in Section 5 below, neither the Seller, nor any
other person on its behalf, has made or makes any additional representations or warranties, express or implied as to any other matter<FONT STYLE="font-family: Times New Roman, Times, Serif">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">5. </FONT><U>REPRESENTATIONS
AND WARRANTIES ON BEHALF OF THE SELLER SUBSIDIARY</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in">The Seller hereby further
represents and warrants to the Purchasers, on behalf of the Seller Subsidiary, that except as set forth on the Disclosure Schedule delivered
by the Seller on the date hereof (the &ldquo;<B>Disclosure Schedule</B>&rdquo;), which exceptions shall be deemed to be part of the representations
and warranties made hereunder, that the following representations and warranties are true and correct in all respects as of the Closing
Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">5.1 </FONT><U>Authorization;
Validity</U>. The Seller Subsidiary is duly incorporated and validly existing and in good standing under the laws of the State of Delaware
and has all requisite corporate power and authority to carry on its business as now conducted. The Seller Subsidiary has and will have
at the Closing the corporate power and authority to carry out and perform its obligations under the terms of this Agreement. All corporate
actions on the part of the Seller Subsidiary necessary for the authorization, execution, delivery and performance of this Agreement and
the obligations hereunder have been taken.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">5.2 <U>Consents.</U>
The Seller Subsidiary has obtained each consent, approval, permit, declaration, registration, and authorization of, and made each filing
with, any person, including any applicable court, governmental or regulatory authority, commission, administrative agency, and non-governmental
third party, if any, necessary to consummate the Transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">5.3 <U>Non
Contravention</U>. The performance by the Seller Subsidiary of this Agreement or any of the Transaction Agreements to which it is a party,
nor the consummation of the Transactions contemplated hereunder and thereunder, will (with or without notice or lapse of time): (a) contravene,
conflict with or result in a violation of (i) any provision of the organizational documents of the Seller Subsidiary; (ii) any applicable
law; or (iii) any provision of any contract or agreement to which the Seller Subsidiary is a party; or (b) otherwise give any person the
right to (x) declare a default or exercise any remedy under any such contract or agreement, (y) accelerate the maturity or performance
of any such contract or agreement, or (z) cancel, terminate or modify any such contract or agreement, in each case, except as would not
have and would not reasonably be expected to have or result in an adverse effect on the ability of the Seller Subsidiary to consummate
the Transactions contemplated hereunder pursuant to the terms hereof or under the Transaction Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">5.4 <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal"><U>Capitalization</U></FONT>.
The <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">authorized</FONT> capital stock of the Seller Subsidiary
immediately prior to the Closing is 5,000 shares of Common Stock of which 100 shares of Common Stock are issued and outstanding immediately
prior to the issuance of the Conversion Shares and the Closing. The capitalization table of the Seller Subsidiary, reflecting the issued
and outstanding share capital of the Seller Subsidiary on a fully diluted basis, immediately prior to Closing and immediately following
the Closing, after giving effect to the investment of the Purchase Price is attached as <B><U>Schedule 5.4</U></B> of the Disclosure Schedule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">5.5 <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal"><U>Ownership
of Shares</U></FONT>. As of immediately prior to the Closing, the Seller is the sole lawful owner, beneficially and of record, of all
of the issued and outstanding capital stock of the Seller Subsidiary and of all rights thereto, free and clear of all Encumbrances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">5.6 <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal"><U>Directors,
Officers</U></FONT>. The sole directors and officers of the Seller Subsidiary immediately prior to the Closing are the directors and officers
listed on <B><U>Schedule 5.6</U></B> of the Disclosure Schedule. Other than pursuant to the Seller Subsidiary&rsquo;s bylaws, the Seller
Subsidiary has no agreement, obligation or commitment with respect to the election of any individual or individuals to the board of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">5.7 <U>Liabilities</U>.
The Seller Subsidiary does not have any liabilities, debts or obligations, except under this Agreement or any applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">5.8 <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal"><U>Ownership
of Assets</U></FONT>. The Seller Subsidiary does not currently own, lease or license any tangible properties or assets other than the
Business Assets that are listed in <B><U>Schedule 5.8</U></B> of the Disclosure Schedule (the &ldquo;<B>Assets</B>&rdquo;) which are materially
sufficient to enable the Seller Subsidiary to conduct and operate its business in ordinary course as currently conducted, following the
Closing, all of which, to the Seller&rsquo;s knowledge are in good operating condition and repair, ordinary wear and tear excepted, and
are adequate and suitable for their present uses. The Seller Subsidiary owns all right, title and interest in and to the Assets and such
are not subject to any mortgage, pledge, lien, lease, claim, Encumbrance, charge, security interest or other interest or claim of any
kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">5.9 <U>Contracts.</U>
<FONT STYLE="font-family: Times New Roman, Times, Serif">The Seller Subsidiary has no material </FONT>contracts<FONT STYLE="font-family: Times New Roman, Times, Serif">,
agreements, arrangements, understandings, and other obligations and commitments in effect, to which the Seller Subsidiary is a party,
or by which the Seller Subsidiary or the Seller Subsidiary&rsquo;s property is bound. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">5.10 <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal"><U>Employment</U>.
</FONT> At the Closing, the Seller Subsidiary never had nor currently has any employees and/or consultants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">5.11 <FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal"><U>Litigation</U></FONT>.
There is no claim, action, suit, proceeding, arbitration, complaint, dispute, charge or investigation pending, currently threatened, and
no circumstances exist that may give rise to the above-mentioned disputes, claims and proceedings against the <FONT STYLE="font-family: Times New Roman, Times, Serif">Seller
Subsidiary which are related in any way to the Seller Subsidiary&rsquo;s business, its assets and properties. The Seller Subsidiary is
not a party to or subject to the provisions of any order, writ, injunction, judgment or decree of any court or governmental agency or
instrumentality. The Seller is not aware of any fact or have reasonable grounds to be aware of any fact which may result in any such proceedings
against the Seller Subsidiary.</FONT> No product liability claims have been received by any third party against the Seller Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">5.12 <U>Intellectual
Property</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(a) &ldquo;<B>Seller
Subsidiary Intellectual Property</B>&rdquo; means all patents, patent applications, trademarks, trademark applications, service marks,
service mark applications, trade names, copyrights, trade secrets, know-how, inventions, designs, works of authorship, computer programs
and technical data, domain names, mask works, information and proprietary rights and processes, similar or other intellectual property
rights, subject matter of any of the foregoing, tangible embodiments of any of the foregoing, licenses and rights in, to and under any
of the foregoing, in any and all such cases that are owned or used by and to the Seller&rsquo;s knowledge are necessary for the Seller
Subsidiary in the conduct of its business as currently conducted or as currently proposed to be conducted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(b) The
Seller Subsidiary owns or possesses sufficient legal rights to all Seller Subsidiary Intellectual Property without any known conflict
with, or infringement of, the rights of others, including prior employees or consultants, or academic or medical institutions with which
any of them may be affiliated now or may have been affiliated in the past. The Seller Subsidiary has not received any communications alleging
that the Seller Subsidiary has violated, or by conducting its business, would violate any of the patents, trademarks, service marks, tradenames,
copyrights, trade secrets, mask works or other proprietary rights or processes of any other person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(c) Other
than with respect to commercially available software products under standard end-user object code license agreements, there are no outstanding
options, licenses, agreements, claims, Encumbrances or shared ownership interests of any kind relating to the Seller Subsidiary Intellectual
Property, nor is the Seller Subsidiary bound by or a party to any options, licenses or agreements of any kind with respect to the patents,
trademarks, service marks, trade names, copyrights, trade secrets, licenses, information, proprietary rights and processes of any other
person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(d) The
Seller Subsidiary has obtained and possesses valid licenses to use all of the software programs present on the computers and other software-enabled
electronic devices that it owns or leases or that it has otherwise provided to its employees for their use in connection with the Seller
Subsidiary&rsquo;s business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(e) <B><U>Schedule
5.12(e)</U></B> of the Disclosure Schedule lists all patents, patent applications, registered trademarks, trademark applications, service
marks, service mark applications, tradenames, registered copyrights, and licenses to and under any of the foregoing, in each case owned
by the Seller Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(f) No
government funding, facilities of a university, college, other educational institution or research center, or funding from third parties
was used in the development of any Seller Subsidiary Intellectual Property. No person who was involved in, or who contributed to, the
creation or development of any Seller Subsidiary Intellectual Property, has performed services for the government, university, college,
or other educational institution or research center in a manner that would affect Seller Subsidiary&rsquo;s rights in the Seller Subsidiary
Intellectual Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(g) No
Seller Subsidiary Intellectual Property was placed in escrow, the Seller Subsidiary is under no obligation (contingent or otherwise) to
place any Seller Subsidiary Intellectual Property into escrow, and no plans for such exist.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">5.13 <U>Compliance
with Other Instruments</U>. The Seller Subsidiary is not in violation or default (i) of any provisions of its Bylaws, (ii) of any instrument,
judgment, order, writ or decree, (iii) under any note, indenture or mortgage, or (iv) under any lease, agreement, contract or purchase
order to which it is a party or by which it is bound that is required to be listed on the Disclosure Schedule, or (v) of any provision
of federal or state statute, rule or regulation applicable to the Seller Subsidiary. The execution, delivery and performance of the Transaction
Agreements and the consummation of the Transactions contemplated by the Transaction Agreements will not result in any such violation or
be in conflict with or constitute, with or without the passage of time and giving of notice, either (i) a default under any such provision,
instrument, judgment, order, writ, decree, contract or agreement; or (ii) an event which results in the creation of any lien, charge or
Encumbrance upon any assets of the Seller Subsidiary or the suspension, revocation, forfeiture, or nonrenewal of any material permit or
license applicable to the Seller Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">5.14 <U>Taxes</U>.
The Seller Subsidiary has duly and timely filed all tax returns and reports (including information returns and reports) as required by
applicable law. Each such return or report was true and complete in all material respects when filed. None of such returns or reports
has been audited by any taxing authority and the Seller Subsidiary has not been advised that any of such returns or reports will be audited.
There is no pending (or threatened by written notice delivered to the Seller Subsidiary prior to the date hereof) dispute, examination,
audit, claim or other action concerning any tax or tax return of the Seller Subsidiary claimed or raised by any tax authority. Any and
all taxes and other charges due by the Seller Subsidiary to any local or foreign tax authorities (including, without limitation, those
due in respect of the properties, income, franchises, licenses, sales or payrolls) have been timely paid. The Seller Subsidiary has never
had any tax deficiency proposed or assessed against it and has not executed any waiver of any statute of limitations on the assessment
or collection of any tax or governmental charge. The Seller Subsidiary has not incurred any taxes, assessments or governmental charges
other than in the ordinary course of business. The Seller Subsidiary is not and has never been subject to tax in any country other than
its jurisdiction of incorporation by virtue of being treated as a resident of or having a permanent establishment or other place of business
in that country, and no claim has ever been made by a tax authority in a jurisdiction where the Seller Subsidiary does not file tax returns
that it is or may be subject to taxation by that jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">5.15 <U>Insurance</U>.
<B><U>Schedule </U></B><U>&lrm;<B>5.15</B></U> of the Disclosure Schedule sets forth a true and accurate list of the Seller Subsidiary&rsquo;s
insurance policies which are reasonably sufficient in amount (subject to reasonable deductions) to allow it to replace any of its properties
that might be damaged or destroyed and to insure the risks associated with its Business and affairs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">5.16 <U>Data
Privacy</U>. In connection with its collection, storage, use and/or disclosure of any information that constitutes &ldquo;personal information,&rdquo;
&ldquo;personal data&rdquo; or &ldquo;personally identifiable information&rdquo; as defined in applicable laws (collectively &ldquo;<B>Personal
Information</B>&rdquo;) by or on behalf of the Seller Subsidiary, the Seller Subsidiary is and has been in compliance with (i) all applicable
laws (including, without limitation, laws relating to privacy, data security, telephone and text message communications, and marketing
by email or other channels) in all relevant jurisdictions, (ii) the Seller Subsidiary&rsquo;s privacy policies and public written statements
regarding the Seller Subsidiary&rsquo;s privacy or data security practices, and (iii) the requirements of any contract codes of conduct
or industry standards by which the Seller Subsidiary is bound.<FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP></SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">5.17 <U>Disclosure</U>.
The Seller Subsidiary has made available to the Purchasers all the information that the Purchasers have requested for deciding whether
to acquire the Sellers Shares and the Seller Exchange Shares. All disclosures provided to the Purchasers regarding the Seller Subsidiary,
its business and the Transactions contemplated hereby, including the exhibits to this Agreement, furnished by the Seller with respect
to the representations and warranties made herein are true and correct with respect to such representations and warranties and do not
contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein,
in light of the circumstances under which they were made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">5.18 <U>No
Brokers</U>. No broker or finder has acted directly or indirectly for the Seller Subsidiary in connection with this Agreement or the Transactions,
and no broker or finder is entitled to any brokerage or finder&rsquo;s fee or other commission in respect thereof based in any way on
agreements, arrangements or understandings made by or on behalf of the Seller Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">5.19 <U>Exclusive
Representation</U>. The representations and warranties set forth in this Section 5 above are the only representations and warranties made
by the Seller on behalf of the Seller Subsidiary and neither the Seller, nor any other person on their behalf, has made or makes any additional
representations or warranties, express or implied as to any matter on behalf of the Seller Subsidiary<FONT STYLE="font-family: Times New Roman, Times, Serif">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">6. </FONT><U>REPRESENTATIONS
AND WARRANTIES OF THE PURCHASERS.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in">The Purchasers each
hereby represent and warrant, severally and jointly to the Seller, that the following representations and warranties are true and correct
in all respects as of the Closing Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">6.1 <U>Authorization;
Validity.</U> The Purchasers are duly incorporated and validly existing under the laws of their respective jurisdiction of incorporation.
Each of the Purchasers has the requisite corporate power and authority to execute and deliver this Agreement and to perform its obligations
hereunder. This Agreement has been duly executed and delivered and, assuming due execution and delivery by the other party, constitutes
the valid and binding obligation of the parties, enforceable in accordance with its terms and conditions except as may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium laws, and other laws of general application affecting the enforcement of creditors&rsquo;
rights and remedies generally.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">6.2 <U>Consents.</U>
Each of the Purchasers has obtained each consent, approval, permit, declaration, registration, and authorization of, and made each filing
with, any person, including any applicable court, governmental or regulatory authority, commission, administrative agency, and non-governmental
third party, if any, necessary to consummate the Transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">6.3 <U>Non
Contravention</U>. Neither the execution, delivery or performance by the any of the Purchasers of this Agreement or any of the Transaction
Agreements to which it is a party, nor the consummation of the Transactions contemplated hereunder and thereunder, will (with or without
notice or lapse of time): (a) contravene, conflict with or result in a violation of (i) any provision of the organizational documents
of the parties; (ii) any applicable law; or (iii) any provision of any contract or agreement to which the Seller and the Purchasers are
a party; or (b) otherwise give any person the right to (x) declare a default or exercise any remedy under any such contract or agreement,
(y) accelerate the maturity or performance of any such contract or agreement, or (z) cancel, terminate or modify any such contract or
agreement, in each case, except as would not have and would not reasonably be expected to have or result in an adverse effect on the ability
of the Purchasers to consummate the Transactions contemplated hereunder pursuant to the terms hereof or under the Transaction Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">6.4 <U>Parent
Exchange Shares</U>. The Parent represents and warrants that the Parent Exchange Shares to be issued will be, when issued, in accordance
with the terms thereof, duly authorized, validly issued, fully paid and non-assessable and free of Encumbrances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">6.5 <U>Acquisition
of the Exchange Shares for Investment</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(a) <U>Purchase
Entirely for Own Account</U>. The Seller Shares and the Seller Exchange Shares proposed to be acquired by the Purchasers hereunder will
be acquired for investment for each party&rsquo;s own account and not as a nominee or agent, and not with a view to the resale or distribution
of any part thereof, and each party has no present intention of selling, granting any participation in or otherwise distributing the Seller
Shares and the Seller Exchange Shares, except in compliance with applicable securities laws. Each of the Purchasers further represents
that it does not have any contract, undertaking, agreement or arrangement with any person to sell, transfer or grant participation to
such Person with respect to the Seller Shares and the Seller Exchange Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(b) The
Purchasers (i) can bear the economic risk of its investment and (ii) possess such knowledge and experience in financial and business matters
that it is capable of evaluating the merits and risks of its investment in the other party and its securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(c) Each
of the Purchasers understands that the sale of the Seller Exchange Shares is not registered under the Securities Act and that the issuance
hereof is intended to be exempt from registration under Regulation D. Each of the Purchasers is an &ldquo;accredited investor,&rdquo;
as such term is defined in Rule 501 of Regulation D or, if not an accredited investor, otherwise meets the suitability requirements of
Regulation D and Section 4(a)(2) of the Securities Act. The certificates representing the Seller Exchange Shares issued shall be endorsed
with the following legends, in addition to any other legend required to be placed thereon by applicable securities laws:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0cm">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0cm"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0cm">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0cm">&ldquo;THIS SECURITY
HAS BEEN ACQUIRED FOR INVESTMENT AND HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT&nbsp;OF 1933, AS AMENDED (&ldquo;SECURITIES ACT&rdquo;),
OR APPLICABLE STATE SECURITIES OR &ldquo;BLUE SKY&rdquo; LAWS.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0cm">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0cm">&ldquo;TRANSFER OF THESE
SECURITIES IS PROHIBITED UNLESS A REGISTRATION STATEMENT UNDER THE SECURITIES ACT WITH RESPECT TO SUCH SECURITY SHALL THEN BE IN EFFECT
AND SUCH TRANSFER HAS BEEN QUALIFIED UNDER ALL APPLICABLE STATE SECURITIES OR &ldquo;BLUE SKY&rdquo; LAWS, OR AN EXEMPTION THEREFROM SHALL
BE AVAILABLE UNDER THE ACT AND SUCH LAWS.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(d) The
Purchasers acknowledge that neither the SEC, nor the securities regulatory body of any state or other jurisdiction, has received, considered
or passed upon the accuracy or adequacy of the information and representations made in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(e) The
Purchasers acknowledge that it has carefully reviewed such information as it has deemed necessary to evaluate an investment in the other
party and its securities. To the full satisfaction of each of the Purchasers, it has been furnished all materials that it has requested
relating to the Seller Shares, the Seller Exchange Shares and the issuance of the Shares hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(f) <U>No
Market</U>. The Purchaser acknowledges and agrees that there is currently no public market for the Seller Shares and that the Seller Subsidiary
or the Seller has no obligation to apply to list the Seller Shares on any securities exchange or national market, consequently, the Purchaser
should assume that it is very unlikely that any public market for the Seller Shares will ever develop. The Purchasers understand and agree
that Seller has made no representations or warranties to the Purchaser respecting any such listing or the Seller Subsidiary&rsquo;s intentions
with respect thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(g) <U>Additional
Legend; Consent</U>. Additionally, the Shares will bear any legend required by the &ldquo;blue sky&rdquo; laws of any state to the extent
such laws are applicable to the securities represented by the certificate so legended and each party consents to the other party making
a notation on its records or giving instructions to any transfer agent of the Shares in order to implement the restrictions on transfer
of the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">6.6 <U>Compliance</U>.
The Purchasers have not been advised, nor does it have reason to believe, that it is not conducting its business in compliance with all
applicable laws, rules and regulations of the jurisdictions in which it is conducting its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">6.7 <U>Conformity
of Descriptions</U>. The Parent Exchange Shares when issued, will conform in all material respects to the descriptions of the Shares contained
in the Parent&rsquo;s filings with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">6.8 <U>Disclosure
Controls</U>. The Parent has disclosure controls and procedures (as defined in Rule 13a-15 under the Exchange Act) that are designed to
ensure that material information relating to it is made known to its principal executive officer and principal financial officer or persons
performing similar functions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">6.9 <U>Disclosure</U>.
All disclosures provided to the Seller regarding the Purchasers, its business and the Transactions contemplated hereby, including the
exhibits to this Agreement, furnished by the Purchasers with respect to the representations and warranties made herein are true and correct
with respect to such representations and warranties and do not contain any untrue statement of a material fact or omit to state any material
fact necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">6.10 <U>No
Brokers</U>. No broker or finder has acted directly or indirectly for the Purchasers in connection with this Agreement or the Transactions,
and no broker or finder is entitled to any brokerage or finder&rsquo;s fee or other commission in respect thereof based in any way on
agreements, arrangements or understandings made by or on behalf of the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">6.11 <U>Exclusive
Representation</U>. The representations and warranties set forth in this Section 6 above are the only representations and warranties made
by the Purchasers with respect to the matters contained herein and, neither the Purchasers, nor any other person on their behalf, has
made or makes any additional representations or warranties, express or implied as to any other matter<FONT STYLE="font-family: Times New Roman, Times, Serif">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">7. </FONT><U>COVENANTS</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">7.1 <U>Securities
Law Compliance</U>. Each of the Seller and the Purchasers understands and agrees that the consummation of this Agreement, including the
transfer or issuance, as applicable, of the Shares at the Closing, constitutes the offer and sale of securities under the Securities Act
and applicable state statutes. Each of the Seller and the Purchasers agree that such Transactions shall be consummated in reliance on
exemptions from the registration requirements of such statutes, which depend, among other items, on the circumstances under which such
securities are acquired. Furthermore, in connection with the Transactions contemplated by this Agreement, the Seller and the Purchasers
shall each file, with the assistance of the other and their respective legal counsel, such notices, applications, reports or other instruments
as may be deemed by them to be necessary or appropriate in an effort to document reliance on such exemptions, all to the extent and in
the manner as may be deemed by the parties to be appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">7.2 <U>Commercially
Reasonable Efforts</U>. Upon the terms and subject to the conditions set forth in this Agreement, each of the parties agrees to use its
commercially reasonable efforts to take, or cause to be taken, all actions, and to do, or cause to be done, and to assist and cooperate
with the other parties in doing, all things necessary, proper or advisable to consummate and make effective, in the most expeditious manner
practicable the Transactions. The parties hereto will use their commercially reasonable efforts and cooperate with one another (i) in
promptly determining whether any filings are required to be made or consents, approvals, waivers, permits or authorizations are required
to be obtained (or, which if not obtained, would result in an event of default, termination or acceleration of any agreement or any put
right under any agreement) under any applicable law or regulation or from any governmental authorities or third parties in connection
with the Transactions contemplated by this Agreement; and (ii) in promptly making any such filings, in furnishing information required
in connection therewith and in timely seeking to obtain any such consents, approvals, permits or authorizations. The parties hereto shall
mutually cooperate in order to facilitate the achievement of the benefits reasonably anticipated from the Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">7.3 <U>Further
Assurances</U>. Subject to the terms and conditions herein provided, each of the Seller and the Purchasers shall use its reasonable efforts
to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under applicable
laws and regulations to consummate and make effective this Agreement and the Transactions contemplated herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">7.4 <U>Assumption
of Liabilities</U>. At the Closing, the Parent shall assume from the Seller, and agrees to pay, perform and discharge in accordance with
the terms thereof, of 49.5% of all of the Seller&rsquo;s duties, liabilities and obligations arising under the Assignment and Assumption
Agreement, dated as of September 12, 2022, by and between the Seller and M.R.M. Merhavit Holdings and Management Ltd. and any and all
ancillary agreements, exhibits, documents, certificates and instruments contemplated thereby, including the Asset Purchase Agreement attached
thereto as Exhibit A and dated as of September 12, 2022; all of which are specified to be performed by the Seller pursuant to the terms
thereof as of the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"></FONT></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">8. </FONT><U>TAX
MATTERS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">8.1 Each
of the Seller and Purchasers has had an opportunity to review the federal, state and local tax consequences of the transfer or issuance,
as applicable, of the Shares hereunder with his or its own tax advisors, and each party is relying solely on such advisors and not on
any statements or representations of the other parties or any of their respective agents or representatives. Each of the Seller and the
Purchasers acknowledges that the Transactions constitute transactions solely among the Purchasers and the Seller negotiated at arms&rsquo;
length and that the Purchase Price is paid solely as consideration for the Seller Shares, such that receipt of the Purchase Price will
be treated by Seller as an amount realized on the sale of the Seller Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">8.2 <U>Withholding</U>.
Each party acknowledges and agrees that any tax consequences arising from the Transactions or any other event or act hereunder, shall
be borne solely by the respective party and that the respective party may withhold the amount of the tax and/or other mandatory payment
of which is required with respect to the Transactions in accordance with the tax withholdings approval provided by the respective party
from time to time. In the event that either party determines that it is required to withhold any tax as a result of the issuance or transfer,
as applicable, of the Shares, as a condition to each issuance or transfer, as applicable, of the Shares, the other party hereto shall
make arrangements satisfactory to the respective party to enable it to satisfy all withholding requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">9. </FONT><U>INDEMNIFICATION</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">9.1 <U>Effectiveness;
Survival</U>. Each party has the right to fully rely upon the representations, warranties and covenants of the other party hereto (as
applicable, severally and not jointly, the &ldquo;<B>Indemnitor</B>&rdquo;) contained in or made pursuant to this Agreement and in the
schedules attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt">(a) The
representations and warranties of each the parties contained in or made pursuant to this Agreement shall survive the execution and delivery
of this Agreement and the Closing until: (i) in case of Sections 4.1, 4.2, 4.3, 4.4, 4.5, 5.1, &lrm;5.2<I>, </I>5.3, 5.4, 5.14, 6.1, 6.2,
6.3 and 6.4 (the representations and warranties referred to in this clause (i), collectively, the &ldquo;<B>Fundamental Representations</B>&rdquo;),
until the expiration of the applicable statute of limitation period; and (ii) other than as set forth in clause (i) above, the 36<SUP>th</SUP>
months anniversary of the Closing Date; in each case, with respect to any theretofore un-asserted claims as set forth in clause (b) below;
<I>provided, however</I>, that no limitation shall apply to breach of any representation or warranty which constitutes fraud or willful
misrepresentation by the any of the parties hereto (as the case may be) (&ldquo;<B>Fraud</B>&rdquo;). The applicable survival period shall
be referred to, as applicable, as the &ldquo;<B>Claims Period</B>&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt">(b) Except
for Fraud, neither party shall have any liability with respect to any breach of representation and warranty included in this Section 9,
unless a claim is made hereunder prior to the expiration of the Claims Period for such representation and warranty, in which case such
representation and warranty shall survive as to that claim until the claim has been finally resolved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">9.2 <U>Indemnifiable
Losses</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Indemnitor shall indemnify
the respective party (including its stockholders, directors and officers) (each, an &ldquo;<B>Indemnitee</B>&rdquo;) against, and hold
each Indemnitee harmless and pay on behalf of or reimburse the Indemnitee in respect of the entirety of any claims, actions, suits, settlements,
damages, expenses (including, reasonable legal costs and expenses), losses, or costs sustained or incurred by such Indemnitees (collectively,
&ldquo;<B>Losses</B>&rdquo;) which the Indemnitee may incur, suffer, sustain or become subject to, as a result of, arising out of, relating
to or in connection with any allegation or claim in respect of any of the following (subject to the limitations in this Section 9):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(a) any
failure of any representation or warranty made by the Indemnitor in this Agreement or in any Transaction Document (including, the Disclosure
Schedule, and any exhibit or schedule thereto) to be true and correct as of the date of this Agreement and as of the Closing Date as though
such representation or warranty were made as of the Closing Date, provided however that the Purchasers&rsquo; liability and indemnification
obligations hereunder shall be limited to failure of representations or warranties relating to or arising out of, the Parent Exchange
Shares;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(b) any
breach, default or violation of any covenant or obligation of, or agreement by an Indemnitor (prior to Closing) contained in this Agreement
or in any other Transaction Document;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(c) solely
with respect to indemnification by the Seller, any loans, liabilities or obligations of the Indemnitor (including, without duplication,
the Debt Amount and the Signing Bonus) whether or not such loans, liabilities or obligations are known or unknown, contingent or fixed,
or matured or unmatured, whether or not such Losses are caused by the negligence or misconduct of the Indemnitor, existing as of the Closing
Date or arising after the Closing Date (collectively, the &ldquo;<B>Liabilities</B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(d) solely
with respect to indemnification by the Seller, any taxes, charges, duties, fees, levies, imposts or other assessments, reassessments,
or mandatory payments of any kind whatsoever, whether direct or indirect, imposed by or payable to or accrued to the benefit of any federal,
state, municipal, local or foreign tax authority, owed or that may become owed by the Seller Subsidiary with respect to any period ending
on (and including) the Closing Date; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(e) any
Fraud by or on behalf of the Indemnitor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">9.3 <U>Limitations</U>.
The Indemnitee&rsquo;s right for indemnification hereunder is subject to the following conditions and limitations, notwithstanding anything
to the contrary in this Agreement, but in addition to any other limitation or condition contained herein; <I>provided, however</I>, that
no such limitation shall apply to Fraud:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(a) Other
than in respect of the Fundamental Representations, no Indemnitor shall be liable for any Loss, unless and until the aggregate of Losses
equal or exceeds $50,000, in which case indemnification shall be made from the first dollar amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(b) The
Indemnitor&rsquo;s liability amount shall be limited to the Purchase Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1.5in">(c) No
Indemnitor shall be liable for any lost profits, business interruption, or for any indirect, incidental, consequential, exemplary or punitive
damages arising out of or relating to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">9.4 <U>Claims
Notice; Third Party Claims</U>. In the event that an Indemnitee wishes to assert a claim for indemnification hereunder it shall give the
Indemnitor a prompt written notice thereof (a &ldquo;<B>Claims Notice</B>&rdquo;), which shall describe in reasonable detail the facts
and circumstances upon which the asserted claim for indemnification is based and thereafter keep the Indemnitor informed, in all material
respects, with respect thereto. In the event that such Claims Notice results from a third party claim against the Indemnitee, such Indemnitee
shall promptly upon becoming aware of the commencement of proceedings by such third party provide the Indemnitor with the Claims Notice
and the Indemnitor shall have the right to assume the defense thereof (at Indemnitor&rsquo;s expense) with counsel mutually satisfactory
to the parties; <I>provided, however</I>, that the Indemnitees shall have the right to retain their own counsel, at the reasonable expense
of the Indemnitor, and within the indemnification limitations herein, if representation of all parties by the counsel retained by the
Indemnitor would be inappropriate due to actual or potential differing interests between the parties in such proceeding. Failure of the
Indemnitees to give prompt notice or to keep it informed, as provided herein, shall not relieve the Indemnitor of any of its obligations
hereunder, except to the extent that the Indemnitor is actually and materially prejudiced by such failure. The Indemnitor shall not be
liable nor shall it be required to indemnify or hold harmless the Indemnitee in connection with any settlement effected without its consent
in writing, which shall not be unreasonably withheld or delayed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">9.5 <U>Sole
Remedy</U>. The indemnification provided by the Indemnitor hereunder and the enforcement of such indemnification shall be the exclusive
remedy available to the Indemnitees under this Agreement, other than for Fraud; <I>provided</I> that this provision does not limit the
right to seek specific performance, a restraining order or injunctive relief with respect to any provision of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">10. </FONT><U>GENERAL
PROVISIONS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">10.1 <U>Successors
and Assigns; Assignment</U>. Except as otherwise provided for herein, this Agreement, and the rights and obligations of the parties hereunder,
will be binding upon and inure to the benefit of their respective successors, assigns, heirs, executors, administrators and legal representatives.
Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto any rights, remedies,
obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement The Seller may assign
any of its rights and obligations under this Agreement to its successors and assigns after the Closing, subject to the assumption by such
successors and assigns of this Agreement or any and all of its rights, privileges or obligations hereunder. No other party to this Agreement
may assign, whether voluntarily or by operation of law, any of its rights and obligations under this Agreement, except with the prior
written consent of the Seller, which shall not be unreasonably withheld.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">10.2 <U>Governing
Law</U>. This Agreement will be governed by and construed in accordance with the laws of the State of Israel, without giving effect to
that body of laws pertaining to conflict of laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">10.3 <U>Notices</U>.
Any and all notices required or permitted to be given to a party pursuant to the provisions of this Agreement will be in writing and will
be effective and deemed to provide such party sufficient notice under this Agreement on the earliest of the following: (a)&nbsp;at the
time of personal delivery, if delivery is in person; (b)&nbsp;one (1) business day after deposit with an express overnight courier for
United States deliveries, or two (2) business days after such deposit for deliveries outside of the United States; or (c)&nbsp;three (3)
business days after deposit in the United States mail by certified mail (return receipt requested) for United States deliveries. All notices
for delivery outside the United States will be sent by express courier. All notices not delivered personally will be sent with postage
and/or other charges prepaid and properly addressed to the party to be notified at the address set forth below the signature lines of
this Agreement or at such other address as such other party may designate by one of the indicated means of notice herein to the other
party hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">10.4 <U>Delays
or Omissions</U>. Except as expressly provided herein, no delay or omission to exercise any right, power or remedy accruing to any party
to this Agreement upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of
such non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of any
similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach
or default therefore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party
of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement,
must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement
or by law or otherwise afforded to any party to this Agreement, shall be cumulative and not alternative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">10.5 <U>Further
Assurances</U>. From and after the date of this Agreement, upon the request of Seller or the Purchasers, such other party agrees to execute
such further documents and instruments and to take such further actions as may be reasonably necessary to carry out the purposes and intent
of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">10.6 <U>Titles
and Headings</U>. The titles, captions and headings of this Agreement are included for ease of reference only and will be disregarded
in interpreting or construing this Agreement. Unless otherwise specifically stated, all references herein to &ldquo;sections&rdquo; and
&ldquo;exhibits&rdquo; will mean &ldquo;sections&rdquo; and &ldquo;exhibits&rdquo; to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">10.7 <U>Entire
Agreement</U>. This Agreement (including the exhibits and the schedules hereto) and the other documents referred to herein constitute
the entire agreement and understanding of the parties with respect to the subject matter of this Agreement, and supersede all prior understandings
and agreements, whether oral or written, between or among the parties hereto with respect to the specific subject matter hereof. This
Agreement shall not be effective until signed by all parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">10.8 <U>Severability</U>.
If any provision of this Agreement is determined by any court or arbitrator of competent jurisdiction to be invalid, illegal or unenforceable
in any respect, such provision will be enforced to the maximum extent possible given the intent of the parties hereto. If such clause
or provision cannot be so enforced, such provision shall be stricken from this Agreement and the remainder of this Agreement shall be
enforced as if such invalid, illegal or unenforceable clause or provision had (to the extent not enforceable) never been contained in
this Agreement. Notwithstanding the forgoing, if the value of this Agreement based upon the substantial benefit of the bargain for any
party is materially impaired, which determination as made by the presiding court or arbitrator of competent jurisdiction shall be binding,
then both parties agree to substitute such provision(s) through good faith negotiations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">10.9 <U>Amendment
and Waivers</U>. This Agreement may be amended, waived or modified only by a written agreement executed by each of the parties hereto.
Any amendment effected in accordance with this section will be binding upon all parties hereto and each of their respective successors
and assigns. No delay or failure to require performance of any provision of this Agreement shall constitute a waiver of that provision
as to that or any other instance. No waiver granted under this Agreement as to any one provision herein shall constitute a subsequent
waiver of such provision or of any other provision herein, nor shall it constitute the waiver of any performance other than the actual
performance specifically waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">10.10 <U>Counterparts;
Facsimile Signatures</U>. This Agreement may be executed in any number of counterparts, each of which when so executed and delivered will
be deemed an original, and all of which together shall constitute one and the same agreement. This Agreement may be executed and delivered
by facsimile or other means of electronic delivery and upon such delivery, the facsimile signature will be deemed to have the same effect
as if the original signature had been delivered to the other party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">10.11 <U>Specific
Performance</U>. Unless this Agreement has been terminated, each party to this Agreement acknowledges and agrees that any breach by it
of this Agreement shall cause any (or either) of the other parties irreparable harm which may not be adequately compensable by money damages.
Accordingly, except in the case of termination, in the event of a breach or threatened breach by a party of any provision of this Agreement,
each party shall be entitled to seek the remedies of specific performance, injunction or other preliminary or equitable relief, without
having to prove irreparable harm or actual damages. The foregoing right shall be in addition to such other rights or remedies as may be
available to any party for such breach or threatened breach, including but not limited to the recovery of money damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">10.12 <U>Waiver
of Conflict; Acknowledgment</U>. Each of the Seller and the Purchasers acknowledges and agrees that it was advised, prior to the date
hereof, that the law firm Meitar, Law Offices (&ldquo;<B>Meitar</B>&rdquo;), is representing the Seller and the Purchasers in connection
with this Agreement and the Transactions contemplated hereby, that the Seller and the Purchasers have previously provided their consent
to the foregoing in accordance with the applicable rules and that no other party shall have any right, claim or demand against any party,
Meitar or any of its employees, partners or representatives with respect to the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center; text-indent: 0cm"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-weight: normal">[<I>Signature
Page Follows</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
the parties have caused this Stock Purchase Agreement to be executed by its duly authorized representative as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0cm">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><U>PARENT</U>:</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; font-variant: small-caps">JEFFS&rsquo; BRANDS LTD</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%">/s/ Victor Hachmon</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Name:&nbsp;</TD>
    <TD>Victor Hachmon</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD> Chief Executive Officer</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Ronen Zayelet</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Ronen Zayelet</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Chief Financial Officer</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><U>PURCHASER</U>:</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; font-variant: small-caps">NEWCO INC. (under formation)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Victor Hachmon</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Victor Hachmon</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Chief Executive Officer</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Ronen Zayelet</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Ronen Zayelet</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Chief Financial Officer</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><U>SELLER</U>:</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold">SCISPARC LTD.</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Itschak Shrem</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Itschak Shrem</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Director</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Amnon Ben Shai</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Amnon Ben Shai</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Director</TD></TR>
  </TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 18; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0cm"><B><U>SCHEDULE I</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0cm"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The &ldquo;<B>Share Price</B>&rdquo; means the
average closing price of one share on the Nasdaq Capital Market for a period of 30 consecutive trading days ending on (and including)
the third trading day immediately prior to the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt"><B>Seller Exchange Shares</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt"><B>Parent Exchange Shares</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 77%; font-weight: bold; text-align: left">Share Price</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD>
                                                       <TD STYLE="width: 4%; text-align: right"><FONT STYLE="font-size: 10pt">[&#9679;]</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD>
                                                       <TD STYLE="width: 4%; text-align: right"><FONT STYLE="font-size: 10pt">[&#9679;]</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Number of Shares</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-size: 10pt">[&#9679;]</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-size: 10pt">[&#9679;]</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0cm"><B><U>SCHEDULE II</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0cm"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0cm"><B>Price Adjustments</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0cm"><B><U>EXHIBIT A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0cm"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0cm"><B>Consulting Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0cm"><B><U>EXHIBIT&nbsp;B</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0cm"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0cm"><B>Restated Bylaws</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0cm">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0cm"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0cm"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0cm"><B><U>EXHIBIT&nbsp;C</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0cm"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0cm"><B>Signatory Rights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0cm"><B><U>EXHIBIT&nbsp;D</U></B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-decoration: none; text-transform: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-decoration: none; text-transform: none">Stock
Power</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">FOR VALUE RECEIVED and pursuant
to that certain Stock Purchase Agreement dated as of February 23, 2023 (the &ldquo;<B>Agreement</B>&rdquo;), the undersigned hereby sells,
assigns and transfers 56 shares of Common Stock of SciSparc Nutraceuticals Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;)
unto NewCo Inc., a company to be incorporated under the laws of the State of Delaware, as a wholly-owned subsidiary of Jeffs&rsquo; Brands
Ltd, standing in the undersigned&rsquo;s name on the books of the Company delivered herewith, and does hereby irrevocably constitute and
appoint the Secretary of the Company as the undersigned&rsquo;s attorney-in-fact, with full power of substitution, to transfer said stock
on the books of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 5%"></TD>
<TD STYLE="width: 35%; text-align: justify"><FONT STYLE="font-size: 10pt"><B>SCISPARC LTD</B>.</FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
<TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify"></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
<TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
<TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify">&nbsp;</TD>
<TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Dated: </FONT></TD>
<TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-style: normal"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-style: normal"><B>&nbsp;</B></FONT></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>ea174175ex99-3_scisparc.htm
<DESCRIPTION>PRESS RELEASE ISSUED BY SCISPARC LTD. ON FEBRUARY 22, 2023 TITLED "SCISPARC AND CLEARMIND REVEAL THREE UNIQUE COMBINATIONS OF FUTURE PSYCHEDELIC-BASED COMPOUNDS."
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 99.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 18pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 12pt"><B>SciSparc and Clearmind Reveal Three
Unique Combinations of Future Psychedelic-Based Compounds</B></FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Clearmind Medicine submitted patent applications to protect the novel
compounds</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tel Aviv, Israel, Feb. 22, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq:
SPRC) (&ldquo;Company&rdquo; or &ldquo;SciSparc&rdquo;), a specialty clinical-stage pharmaceutical company focusing on the development
of therapies to treat disorders of the central nervous system, announced today that as part of its ongoing collaboration with Clearmind
Medicine Inc. (Nasdaq: CMND) (CSE: CMND), (FSE: CWY) (&ldquo;Clearmind&rdquo;), a biotech company focused on discovery and development
of novel psychedelic-derived therapeutics to solve major under-treated mental health problems, Clearmind has filed three provisional patent
applications with the United States Patent and Trademark Office (USPTO), for unique combinations of future psychedelic-based compounds.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The patent applications refer to novel proprietary combinations of
3,4 Methylenedioxymethamphetamine (MDMA), Ibogaine and Ketamine each with SciSparc&rsquo;s Palmitoylethanolamide (PEA), the active ingredient
of its proprietary CannAmide&trade;.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Overall, as part of this collaboration, six other patent applications
have been filed by Clearmind with the USPTO for various combinations, three of them for the combination of SciSparc&rsquo;s &nbsp;PEA
with Clearmind&rsquo;s MEAI compound (5-methoxy-2-aminoindane) for the treatment of alcohol use disorder, treatment of cocaine addiction
and treatment of obesity and its related metabolic disorders, and recently for novel proprietary combinations of lysergic acid diethylamide
(&ldquo;LSD&rdquo;), psilocybin, and N,N-dimethyltryptamine (&ldquo;DMT&rdquo;) and SciSparc&rsquo;s PEA, the active ingredient of its
proprietary CannAmide&trade;.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As part of the collaboration agreement, any assets generated from the
collaboration will belong to both companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>About&nbsp;SciSparc&nbsp;Ltd. (Nasdaq: SPRC)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U></U></B>SciSparc
Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. SciSparc&rsquo;s
focus is on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the
Company is currently engaged in the following drug development programs based on THC and/or non-psychoactive CBD: SCI-110 for the treatment
of Tourette Syndrome, for the treatment of Alzheimer&rsquo;s disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for
the treatment of ASD and status epilepticus. The Company also has a wholly-owned subsidiary whose business focusses on the sale of hemp-based
products on the Amazon.com marketplace.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>About Clearmind Medicine Inc.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U></U></B>Clearmind
is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to
solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based
compounds and attempt to commercialize them as regulated medicines, foods or supplements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The company&rsquo;s intellectual portfolio currently consists of 13
patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding
the acquisition of additional intellectual property to build its portfolio. Shares of Clearmind are listed for trading on Nasdaq and the
Canadian Securities Exchange under the symbol &ldquo;CMND&rdquo; and the Frankfurt Stock Exchange under the symbol &ldquo;CWY.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B>This press
release contains forward-looking statements within the meaning of the &ldquo;safe harbor&rdquo; provisions of the Private Securities
Litigation Reform Act of 1995 and other Federal securities laws. For example, SciSparc is using forward-looking statements when it discusses
its future psychedelic-based compounds. Historic results of scientific research and clinical and preclinical trials do not guarantee
that the conclusions of future research or trials will suggest identical or even similar conclusions. Because such statements deal with
future events and are based on SciSparc&rsquo;s current expectations, they are subject to various risks and uncertainties and actual
results, performance or achievements of SciSparc could differ materially from those described in or implied by the statements in this
press release. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties,
including those discussed under the heading &ldquo;Risk Factors&rdquo; in SciSparc&rsquo;s Annual Report on Form 20-F filed with the
SEC on&nbsp;April 28, 2022, and in subsequent filings with the U.S. Securities and Exchange Commission. Except as otherwise required
by law, SciSparc disclaims any intention or obligation to update or revise any forward-looking statements, which speak only as of the
date they were made, whether as a result of new information, future events or circumstances or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B>IR@scisparc.com<BR>
Tel: +972-3-6167055</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
